Therapeutic Potential of Laminin–Biodritin Microcapsules for Type 1 Diabetes Mellitus

Pancreatic islet microencapsulation constitutes an attractive therapy for type 1 diabetes mellitus; however, long-term β-cell function remains a major problem. Loss of extracellular matrix interactions during islet isolation dramatically affects β-cell viability. We have previously shown beneficial...

Full description

Bibliographic Details
Main Authors: Ana Lucia Campanha-Rodrigues, Gisella Grazioli, Talita C. Oliveira, Ana Carolina V. Campos-Lisbôa, Thiago R. Mares-Guia, Mari C. Sogayar Ph.D.
Format: Article
Language:English
Published: SAGE Publishing 2015-02-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368913X675160
id doaj-c8fa3818efb048fa9c43f4263183d436
record_format Article
spelling doaj-c8fa3818efb048fa9c43f4263183d4362020-11-25T03:02:54ZengSAGE PublishingCell Transplantation0963-68971555-38922015-02-012410.3727/096368913X675160Therapeutic Potential of Laminin–Biodritin Microcapsules for Type 1 Diabetes MellitusAna Lucia Campanha-Rodrigues0Gisella Grazioli1Talita C. Oliveira2Ana Carolina V. Campos-Lisbôa3Thiago R. Mares-Guia4Mari C. Sogayar Ph.D.5 Chemistry Institute, Biochemistry Department, Cell and Molecular Therapy Center (NUCEL/NETCEM), School of Medicine, University of São Paulo, São Paulo, SP, Brazil Cell Protect Biotechnology Ltda., São Paulo, SP, Brazil Chemistry Institute, Biochemistry Department, Cell and Molecular Therapy Center (NUCEL/NETCEM), School of Medicine, University of São Paulo, São Paulo, SP, Brazil Cell Protect Biotechnology Ltda., São Paulo, SP, Brazil Cell Protect Biotechnology Ltda., São Paulo, SP, Brazil Chemistry Institute, Biochemistry Department, Cell and Molecular Therapy Center (NUCEL/NETCEM), School of Medicine, University of São Paulo, São Paulo, SP, BrazilPancreatic islet microencapsulation constitutes an attractive therapy for type 1 diabetes mellitus; however, long-term β-cell function remains a major problem. Loss of extracellular matrix interactions during islet isolation dramatically affects β-cell viability. We have previously shown beneficial effects of laminin (LN) in human islet cultures. Herein, we investigated whether LN could improve the outcome of transplantation after islet microencapsulation in Biodritin, an alginate-based material. To test LN-Biodritin stability, microcapsules were subjected to different types of in vitro stress. Focusing on biocompatibility, empty microcapsules were coincubated with the RAW 264.7 macrophage cell line for up to 24 h, and empty beads were implanted IP in mice and retrieved for analyses after 7 and 30 days. Upon culturing for 48 h, mRNA, protein levels, and caspase 3 activity were evaluated in islets microencapsulated with LN-Biodritin. Mice rendered diabetic by streptozotocin injection were transplanted with microencapsulated islets, followed by assessment of body weight, glycemia, and graft function (evaluated by OGTT). Graft efficiency was observed upon microencapsulated islet explantation. The results obtained showed that LN-Biodritin microcapsules were as stable and biocompatible as Biodritin. Modulation of mRNA and protein levels suggested protection against apoptosis and islet stress. Mice transplanted with LN-Biodritin microencapsulated islets presented a better outcome at 198 days postsurgery. Graft explantation led animals to hyperglycemia. In conclusion, LN-Biodritin constitutes a very promising biomaterial for islet transplantation.https://doi.org/10.3727/096368913X675160
collection DOAJ
language English
format Article
sources DOAJ
author Ana Lucia Campanha-Rodrigues
Gisella Grazioli
Talita C. Oliveira
Ana Carolina V. Campos-Lisbôa
Thiago R. Mares-Guia
Mari C. Sogayar Ph.D.
spellingShingle Ana Lucia Campanha-Rodrigues
Gisella Grazioli
Talita C. Oliveira
Ana Carolina V. Campos-Lisbôa
Thiago R. Mares-Guia
Mari C. Sogayar Ph.D.
Therapeutic Potential of Laminin–Biodritin Microcapsules for Type 1 Diabetes Mellitus
Cell Transplantation
author_facet Ana Lucia Campanha-Rodrigues
Gisella Grazioli
Talita C. Oliveira
Ana Carolina V. Campos-Lisbôa
Thiago R. Mares-Guia
Mari C. Sogayar Ph.D.
author_sort Ana Lucia Campanha-Rodrigues
title Therapeutic Potential of Laminin–Biodritin Microcapsules for Type 1 Diabetes Mellitus
title_short Therapeutic Potential of Laminin–Biodritin Microcapsules for Type 1 Diabetes Mellitus
title_full Therapeutic Potential of Laminin–Biodritin Microcapsules for Type 1 Diabetes Mellitus
title_fullStr Therapeutic Potential of Laminin–Biodritin Microcapsules for Type 1 Diabetes Mellitus
title_full_unstemmed Therapeutic Potential of Laminin–Biodritin Microcapsules for Type 1 Diabetes Mellitus
title_sort therapeutic potential of laminin–biodritin microcapsules for type 1 diabetes mellitus
publisher SAGE Publishing
series Cell Transplantation
issn 0963-6897
1555-3892
publishDate 2015-02-01
description Pancreatic islet microencapsulation constitutes an attractive therapy for type 1 diabetes mellitus; however, long-term β-cell function remains a major problem. Loss of extracellular matrix interactions during islet isolation dramatically affects β-cell viability. We have previously shown beneficial effects of laminin (LN) in human islet cultures. Herein, we investigated whether LN could improve the outcome of transplantation after islet microencapsulation in Biodritin, an alginate-based material. To test LN-Biodritin stability, microcapsules were subjected to different types of in vitro stress. Focusing on biocompatibility, empty microcapsules were coincubated with the RAW 264.7 macrophage cell line for up to 24 h, and empty beads were implanted IP in mice and retrieved for analyses after 7 and 30 days. Upon culturing for 48 h, mRNA, protein levels, and caspase 3 activity were evaluated in islets microencapsulated with LN-Biodritin. Mice rendered diabetic by streptozotocin injection were transplanted with microencapsulated islets, followed by assessment of body weight, glycemia, and graft function (evaluated by OGTT). Graft efficiency was observed upon microencapsulated islet explantation. The results obtained showed that LN-Biodritin microcapsules were as stable and biocompatible as Biodritin. Modulation of mRNA and protein levels suggested protection against apoptosis and islet stress. Mice transplanted with LN-Biodritin microencapsulated islets presented a better outcome at 198 days postsurgery. Graft explantation led animals to hyperglycemia. In conclusion, LN-Biodritin constitutes a very promising biomaterial for islet transplantation.
url https://doi.org/10.3727/096368913X675160
work_keys_str_mv AT analuciacampanharodrigues therapeuticpotentialoflamininbiodritinmicrocapsulesfortype1diabetesmellitus
AT gisellagrazioli therapeuticpotentialoflamininbiodritinmicrocapsulesfortype1diabetesmellitus
AT talitacoliveira therapeuticpotentialoflamininbiodritinmicrocapsulesfortype1diabetesmellitus
AT anacarolinavcamposlisboa therapeuticpotentialoflamininbiodritinmicrocapsulesfortype1diabetesmellitus
AT thiagormaresguia therapeuticpotentialoflamininbiodritinmicrocapsulesfortype1diabetesmellitus
AT maricsogayarphd therapeuticpotentialoflamininbiodritinmicrocapsulesfortype1diabetesmellitus
_version_ 1724687797613232128